Fluorescence and Glioma Heterogeneity

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions
Malignant Gliomas
Interventions
PROCEDURE

ALA

"Prior to surgery all patients would receive freshly prepared solution of 5-ALA, 20 mg/kg bodyweight dissolved in 100 ml of potable water orally approximately 4 hours (range 4-6 hrs) before the commencement of anesthesia induction for surgery.~The surgery would then be performed with the help of navigation. After craniotomy, the navigation software would be used to identify the selected target areas based on the preoperative images (MR as well as PET when available) and directed image-guided biopsies from these representative areas will be collected for histological evaluation"

Trial Locations (1)

410210

Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Navi Mumbai

All Listed Sponsors
lead

Tata Memorial Hospital

OTHER_GOV

NCT02155452 - Fluorescence and Glioma Heterogeneity | Biotech Hunter | Biotech Hunter